I-NDMA ihlukaniswa njenge-carcinogen yomuntu okungenzeka. Lokhu kusho ukuthi ukuchayeka isikhathi eside ezingeni elingaphezu kwalokho okubhekwa njengokuphephile kungase kwenyuse ingozi yomdlavuza. I-Health Canada yeluleka ngokuthi ayikho ingozi esheshayo ekuqhubekeni nokuthatha i-APO-Amitriptyline noma i-Elavil (amitriptyline) ebuye yakhunjulwa njengoba ingozi engaba khona yomdlavuza ihambisana nokuchayeka isikhathi eside (nsuku zonke iminyaka engu-70) ku-NDMA edlula amazinga aphephile.
I-Health Canada igcina uhlu lwezidakamizwa ezibuyisiwe ze-amitriptyline ezithintwe yile nkinga. Sicela ubheke izeluleko ezigcwele ukuze uthole ulwazi olwengeziwe, okuhlanganisa okwengeziwe ngengozi nokuthi yini okufanele iziguli ziyenze.
| Company | Product | Amandla | DIN | Lot | Ukuphelelwa yisikhathi |
| Inkampani AA Pharma Inc. | Elavil
(I-Amitriptyline Hydrochloride Izibhebhe ze-USP) |
I-10 mg | 00335053 | I-PY1829 | 12/2023 |
| Inkampani AA Pharma Inc. | Elavil (I-Amitriptyline Hydrochloride Izibhebhe ze-USP) |
I-10 mg | 00335053 | I-PY1830 | 12/2023 |
| Inkampani Apotex Inc. | I-APO-Amitriptyline
(I-Amitriptyline Hydrochloride Izibhebhe ze-USP) |
I-10 mg | 02403137 | I-PY1832 | 12/2023 |
